434.3000 -15.90 (-3.53%)
NSE Mar 23, 2026 15:31 PM
Volume: 118.7K
 

Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters unpledged 9.28% of shares in last quarter. Total pledge stands at 26.04% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended